DRKS00027631已完成未知
Randomized, open-label, single dosing, cross-over study to investigate the acceptability, swallowability and palatability of multiple coated drug-free minitablets in young children - Multiple coated drug-free minitablets in young children
Klinik für Allgemeine Pädiatrie, Neonatologie und Kinderkardiologie, Universitätsklinik Düsseldorf0 个研究点目标入组 320 人开始时间: 2022年1月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 1 Months 至 6 Years(—)
- 性别
- All
入选标准
- •1. Children aged from 1 month to 6 years inclusive
- •2. Male and female
- •3. Based on medical history, physical examination, and all other appropriate diagnostic procedures they are able to swallow. Participants suffering from illness must be able to swallow the mini-tablets and to accept the study procedures. This conclusion is based on medical history, physical examination, and all other appropriate diagnostic procedures as assessed by the Principal Investigator, Principal Investigator’s deputies, or sub-investigators.
- •4. Participants and participants’ parents understand and are willing, able, and likely to comply with examination procedures and restrictions.
- •5. Participant and/or participant’s parents or legal guardians are capable of understanding the examination procedures, participant obligations as well as risks and benefits of participation in this study and have given written informed consent and assent where possible.
排除标准
- •Disease/Illness
- •1. Any impairment of swallowing solids as a consequence of chronic illness (e.g. cerebral palsy), acute illness (e.g. sepsis, respiratory distress, gastroenteritis, respiratory tract infection), or oral deformation, as assessed by the Investigator.
- •Intolerance
- •2. Lactose-Intolerance
- •Pre- and Concomitant Medication
- •3. Any drug that causes nausea, fatigue, or palsy
- •Intervention
- •4. Children in the post-operative period who have yet to commence regular oral feeding
- •5. Children, who have eaten one hour before examination and who afterwards feel sick because of the food
研究者
相似试验
尚未招募
不适用
Bioequivalence study of Flecainide 100mg tablet of Vana Darou Gostar Pharm Co., IRAIRCT20190706044111N23Vana Darou Gostar48
尚未招募
Unknown
Bioequivalence study of GLICLAVITE 60mg tablet of Vitabiotics Pharmed Co., IRAIRCT20190706044111N33Vitabiotix Pharmed24
已完成
不适用
Bioequivalence study of Fexofenadine 120mg tablet of Jaber Ebne Hayyan Pharm. Co., IRAIRCT20190706044111N25Jaber Ebne Hayyan Pharm. Co..48
尚未招募
不适用
Bioequivalence study of Dimethyl Fumarate 240mg capsule of Nanoalvand Co., IRAMultiple Sclerosis (MS).Multiple SclerosisIRCT20190706044111N22anoalvand Co.48
尚未招募
不适用
Bioequivalence study of Mebeverin 200mg capsule of Actover Co., IRAIrritable bowel syndromeIRCT20190706044111N29Actover Pharm. Co.24
